Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225796 · ClinicalTrials.gov registry record · Early Phase 1
Study of Sodium Bicarbonate in Kidney Transplant Recipients
A Early Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 29
- Enrollment target
NCT01225796 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 29 participants.
The verdict
NCT01225796, a Early Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of sodium bicarbonate versus no sodium bicarbonate treatment on urinary ammonia levels and urinary transforming growth factor-beta1 (TGF-beta1) excretion in renal transplant patients with low-to-normal serum bicarbonate levels (20 - 28 mmol/L).
Interventions
- DRUG Sodium bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01225796
The ClinicalTrials.gov registry entry for NCT01225796 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sodium bicarbonate is the first listed.
NCT01225796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01225796 about?
NCT01225796 is a clinical study titled "Study of Sodium Bicarbonate in Kidney Transplant Recipients". The purpose of this study is to compare the effect of sodium bicarbonate versus no sodium bicarbonate treatment on urinary ammonia levels and urinary transforming growth factor-beta1 (TGF-beta1) excretion in renal transplant patients with low-to-normal serum bicarbonate levels (20 - 28 mmol/L).
What is the current status of trial NCT01225796?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 29 participants. The study started on 2010-11. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01225796?
The interventions under investigation include: Sodium bicarbonate (DRUG).
Who is sponsoring clinical trial NCT01225796?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.